CompuCyte Corp. (Westwood, MA) and the Program in Cellular and Molecular Medicine at Children's Hospital Boston (aka the Immune Disease Institute, Boston, MA) have announced the establishment of a joint Quantitative Imaging Cytometry program. Under the terms of the agreement, CompuCyte will provide its proprietary laser scanning cytometry instrumentation and technical support programs to trained personnel, and will provide quantitative imaging cytometry and analysis services to the larger Longwood Medical Area community, where the Immune Disease Institute is located.
"CompuCyte's instrumentation provides the ability to combine the quantitative data traditionally generated through flow cytometry with laser-scanned images of cells and tissues, without the traditional flow requirement for harsh sample-processing and the unwanted disturbance of native cells and tissue architecture normally associated with traditional cytometry," explained Dr. Natasha Barteneva, Director of the Flow and Imaging Cytometry Resource of the Program in Cellular and Molecular Medicine and manager of the joint program. "The agreement with CompuCyte expands our capacity in quantitative imaging cytometry and reinforces our commitment to providing our researchers access to the most advanced analytical technologies," stated Dr. Margaret Bradley, Chief Scientific Administrative Officer.
"Laser Scanning Cytometry (LSC) technology has become a gold standard in quantitative automated analysis of intact adherent cells, tissue specimens, tissue microarrays and small cellular samples, such as small needle aspirates," explained Dr. Elena Holden, CompuCyte's President and CEO.
The Program in Cellular and Molecular Medicine at Children's Hospital Boston is a non-profit research institution academically affiliated with Harvard Medical School (HMS), recognized worldwide for its discoveries that increase the body's ability to fight disease. Its mission is fundamental biomedical research to improve human health, harness inflammation, and strengthen immune defense.
CompuCyte is a pioneer in the development of quantitative imaging cytometry instrumentation based on patented laser scanning cytometry technology. The company's iCyte, iCys, and iColor cytometers promise true quantitative cytometric image analysis of cellular and tissue specimens in life science research, drug safety, toxicology studies, biomarker discovery and clinical trials.
More information:
Visit the CompuCyte Corporation website
See also the website for the Immune Disease Institute (the Program in Cellular and Molecular Medicine)
